Clinical Insights on Use of CAR-T Therapy

Opinion
Video

This segment highlights clinical experiences with ide-cel in the second-line setting, focusing on observed improvements in efficacy and quality of life, as well as challenges in administration

Video content above is prompted by the following:

  • Can you share your experience with using ide-cel in the second-line setting?
  • What improvements in efficacy and quality of life have you observed?
  • What challenges have you faced in administering this treatment?
Recent Videos
The dual high-affinity binding observed with ISB 2001 may avoid resistance mechanisms reported with other BCMA-targeted therapies.
2 experts in this video
2 experts in this video
2 experts in this video
2 experts in this video
Related Content